Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03149159
Title Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical University of South Carolina
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field